Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108622052 | 10862205 | 2 | F | 20140212 | 20160825 | 20150224 | 20160902 | PER | US-ELI_LILLY_AND_COMPANY-US201502005043 | ELI LILLY AND CO | 63.48 | YR | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108622052 | 10862205 | 1 | PS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 36 U, TID | 20563 | 36 | IU | INJECTION | TID | ||||||
| 108622052 | 10862205 | 2 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 36 U, TID | C311919H | 20563 | 36 | IU | INJECTION | TID | |||||
| 108622052 | 10862205 | 3 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 36 U, TID | C276683F | 20563 | 36 | IU | INJECTION | TID | |||||
| 108622052 | 10862205 | 4 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 26 U, TID | C503107E | 20563 | 26 | IU | INJECTION | TID | |||||
| 108622052 | 10862205 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 108622052 | 10862205 | 6 | C | TRAMADOL. | TRAMADOL | 1 | U | 0 | |||||||||||
| 108622052 | 10862205 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 108622052 | 10862205 | 8 | C | CARVEDILOL. | CARVEDILOL | 1 | U | 0 | |||||||||||
| 108622052 | 10862205 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108622052 | 10862205 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108622052 | 10862205 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108622052 | 10862205 | Blood glucose decreased | |
| 108622052 | 10862205 | Blood glucose increased | |
| 108622052 | 10862205 | Diverticulitis | |
| 108622052 | 10862205 | Drug ineffective | |
| 108622052 | 10862205 | Headache | |
| 108622052 | 10862205 | Nephrolithiasis | |
| 108622052 | 10862205 | Urinary tract infection | |
| 108622052 | 10862205 | Uterine prolapse | |
| 108622052 | 10862205 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108622052 | 10862205 | 1 | 2006 | 0 |